Veterans Affairs diabetes trial–corrections
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To the Editor: The Supplementary Appendix in which we provided additional information related to our article (Jan. 8 issue)1 contains some errors. In both Appendix 1 and Appendix 2, the heading “6 Year Event Rate” should have read “6-Year Event-free Rate.” We thank the reader who detected this error. In addition, on further examination of the data on albuminuria from the Veterans Affairs Diabetes Trial, we found that the data set that we used to evaluate the progression of disease was constructed improperly. As a result, the rates of progression to microalbuminuria and macroalbuminuria were reported in Table 3 of . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During a median follow up of 5.6 years, there was a nonsignificant reduction in the primary outcome (first occurrence of a major CV event), but the progression to albuminuria was significantly reduced in the intensive-treatment participants, with 9.1% of participants having significantly reduced progression compared to 13.8% in the standard therapy group.”
From Targets for Glycemic Control (2018) · cites this paper as [26]
Citations
Cites
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Self-citation
Research works printed but not linked: 1
- 10.1056/nejmoa0808431 · DOI · Paper page
Cited by
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“9%) compared with standard glycemic control, but no difference in retinopathy and neuropathy (86,87).”
BackgroundStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Rodbard, H. W., Jellinger, P. S., Davidson, J. A., Einhorn, D., Garber, A. J., Grunberger, G., Handelsman, Y., Horton, E. S., Lebovitz, H., Levy, P., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.6.540 · Cited by 942
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 234
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.016 · Cited by 148
Rosenstock, J., Marx, N., Kahn, S. E., Zinman, B., Kastelein, J. J., Lachin, J. M., Bluhmki, E., Patel, S., Johansen, O.-E., & Woerle, H.-J. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112475102 · Cited by 144
Imran, S. A., Agarwal, G., Bajaj, H. S., & Ross, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.030 · Cited by 113
Glucose targets for preventing diabetic kidney disease and its progression
Ruospo, M., Saglimbene, V. M., Palmer, S. C., De Cosmo, S., Pacilli, A., Lamacchia, O., Cignarelli, M., Fioretto, P., Vecchio, M., Craig, J. C., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010137.pub2 · Cited by 111
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
Hanefeld, M., Duetting, E., & Bramlage, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-135 · Cited by 93
Sakamoto, M., Nishimura, R., Irako, T., Tsujino, D., Ando, K., & Utsunomiya, K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-92 · Cited by 88
Cardiovascular Protection in People With Diabetes
Stone, J. A., Houlden, R. L., Lin, P., Udell, J. A., & Verma, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.024 · Cited by 83
Management of diabetes mellitus in older people with comorbidities
Huang, E. S. (2016) · BMJ · doi:10.1136/bmj.i2200 · Cited by 79
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
Mohan, M., Dihoum, A., Mordi, I. R., Choy, A. M., Rena, G., & Lang, C. C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.746382 · Cited by 77
Taber, D. J., Meadows, H. B., Pilch, N. A., Chavin, K. D., Baliga, P. K., & Egede, L. E. (2013) · Clinical Transplantation · doi:10.1111/ctr.12080 · Cited by 57
Approach to diabetes management in patients with CVD
Lathief, S., & Inzucchi, S. E. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.05.005 · Cited by 56
The Impact of Hypoglycemia on the Cardiovascular System: Physiology and Pathophysiology
Yang, S., Park, K., & Zhou, Y.-J. (2015) · Angiology · doi:10.1177/0003319715623400 · Cited by 55
Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes
Catalán, M., Herreras, Z., Pinyol, M., Sala‐Vila, A., Amor, A. J., de Groot, E., Gilabert, R., Ros, E., & Ortega, E. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.04.009 · Cited by 48
Peripheral artery disease. Part 2: medical and endovascular treatment
Weinberg, M. D., Lau, J. F., Rosenfield, K., & Olin, J. W. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.81 · Cited by 46
Jupiter, D. C., Humphers, J. M., & Shibuya, N. (2013) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2013.10.003 · Cited by 33
Glucose control in diabetes: which target level to aim for?
Laakso, M., & Cederberg, H. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02528.x · Cited by 29
Should A1C Targets Be Individualized for All People With Diabetes?
Teoh, H., Home, P., & Leiter, L. A. (2011) · Diabetes Care · doi:10.2337/dc11-s217 · Cited by 23
Guthrie, G. E., & Bogue, R. J. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.933454 · Cited by 20
Implementationof apharmacist-run telephonic insulin titration service
Weidman-Evans, E., Evans, J. D., Eastwood, R., & Fort, A. (2012) · Journal of the American Pharmacists Association · doi:10.1331/japha.2012.11225 · Cited by 19
Obesity and poor glycemic control in patients with type 2 diabetes
Anari, R., Amani, R., & Veissi, M. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20160320 · Cited by 19
Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM
Kesavadev, J., SADIKOT, S. M., WANGNOO, S. K., Kannampilly, J., Saboo, B., Aravind, S. R., Kalra, S., Makkar, B. M., Maji, D., Saikia, M., et al. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.030 · Cited by 18
Glycated haemoglobin and the incidence of end-stage renal disease in diabetics
Oh, S. W., Kim, Y. C., Koo, H., Jin, D. C., Na, K. Y., Chae, D., Kim, S., & Chin, H. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq707 · Cited by 18
Therapeutic management of diabetic kidney disease
Koya, D., Araki, S., & Haneda, M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00112.x · Cited by 17
Glucose lowering and cardiovascular disease: what do we know and what should we do?
CHENG, A. Y. Y., & Leiter, L. A. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000368194.32356.5f · Cited by 16
Tschöpe, D., Bramlage, P., Schneider, S., & Gitt, A. K. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115610470 · Cited by 12
Shestakova, M. V., Vikulova, O. K., Zheleznyakova, A. V., Kutakova, D. V., Исаков, М. А., & Mokrysheva, N. G. (2025) · Diabetes Mellitus · doi:10.14341/dm13261 · Cited by 10
Blood Pressure and Diabetic Nephropathy
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc10-zb03 · Cited by 9
Rizza, S., Copetti, M., Cardellini, M., Porzio, O., Luzi, A., Pecchioli, C., Martelli, E., Valentini, A., Ippoliti, A., Romeo, F., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.04.019 · Cited by 7
Lin, R.-H., Chen, J., Xu, S., Xu, Y., Pan, K., Wang, L., Zhang, J., Yin, Z., & Huang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117311 · Cited by 5
L’inertie thérapeutique dans le diabète de type 2 : la comprendre sans la banaliser
Halimi, S., & Attali, C. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70077-3 · Cited by 5
Objectifs du contrôle de la glycémie
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.036 · Cited by 4
WITHDRAWN: Targets for Glycemic Control
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.04.008 · Cited by 4
RetractedAldafas, R., Vinogradova, Y., Crabtree, T. S. J., Gordon, J. P., & Idris, I. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109292 · Cited by 3
Blicklé, J. F. (2013) · Les cahiers de l année gérontologique · doi:10.1007/s12612-013-0351-9 · Cited by 3
Bulgakova, S. V., Merzlova, P. Y., Kurmaev, D. P., & Treneva, E. V. (2024) · Russian Journal of Geriatric Medicine · doi:10.37586/2686-8636-1-2024-30-39 · Cited by 3
Komishon, A. (2014) · TSpace (University of Toronto) · Cited by 2
Glucose targets for preventing diabetic kidney disease and its progression
Cosmo, S. D., Pacilli, A., Lamacchia, O., Cignarelli, M., Fioretto, P., Vecchio, M., & Strippoli, G. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010137 · Cited by 2
Managing the Broad Spectrum of Type 2 Diabetes
Fleury‐Milfort, E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00004-8 · Cited by 1
Hao, Y.-D., Hao, P., Wang, Z., Zhao, Y., Zhou, Z., Liu, Y., Jia, D., Han, H., Hu, B., Shen, H., et al. (2020) · PubMed Central · doi:10.11909/j.issn.1671-5411.2020.09.004 · Cited by 1
Bondarenko, O. N., Yaroslavceva, M. V., Galstyan, G. R., Larina, V. A., Petrosyan, A. S., & Mokrysheva, N. G. (2024) · Diabetes Mellitus · doi:10.14341/dm13038 · Cited by 1
Determining the Effect of Small Doses of Fructose and its Epimers on Glycemic Control
Noronha, J. C. (2017) · TSpace (University of Toronto) · Cited by 1
2. Therapeutic Strategy for Diabetic Nephropathy.
Koya, D. (2011) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.100.2592
Importance of glycemic control.
Shahady, E. J. (2011) · PubMed
Diabetes mellitus bei multimorbiden Patienten: Klinische Besonderheiten
Wernecke, J. (2017) · Der Diabetologe · doi:10.1007/s11428-016-0180-8
Lozano, S. (2016) · Institutional Repository of the University of Granada (University of Granada)
Dzhun, Y. Y., Marushko, Y. Y., Saienko, Y. A., Rudenko, N. M., & Mankovsky, B. (2022) · Ukrainian journal of cardiovascular surgery · doi:10.30702/ujcvs/22.30(03)/dm031-3543
Metabolisches Gedächtnis bei diabetischer Nierenerkrankung
Biemann, R., & Isermann, B. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01016-5
Tailoring the Treatment of Type 2 Diabetes Mellitus to the Individual
Peter, P. R., & Inzucchi, S. E. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_37
(2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21211-6.00016-2
Guo, M., Duan, H., Ru, D., Yang, S., & Yu, W. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02187-z
Agarwal, S., Basit, M. A., MARBLE, K., Mai, C., Bowen, M. E., Pak, J., Elnakieb, Y. A., & Lingvay, I. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.07.015
Metadata
- Authors
- Moritz, T., Duckworth, W., & Abraira, C.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Moritz, Thomas
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-09-03
- Volume
- 361
- Issue
- 10
- Pages
- 1024-1025
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2004819524
- Cited by
- 55
- References
- 1
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 7 · 2012: 7
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, albuminuria, microalbuminuria, macroalbuminuria, diabetic nephropathy progression, data correction
- MeSH terms
- Albuminuria, Blood Glucose, Creatinine, Diabetes Mellitus, Type 2, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.